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Fasciola hepatica is a parasitic trematode of global importance in livestock. Control strategies reliant 26 
on anthelmintics are unsustainable due to the emergence of drug resistance.  Vaccines are under 27 
development, but efficacy is variable. Evidence from experimental infection suggest vaccine efficacy 28 
may be affected by parasite-induced immunomodulation. Little is known about the immune 29 
response to F. hepatica following natural exposure. Hence we analysed the immune responses over 30 
time in calves naturally exposed to F. hepatica infection. 31 
Cohorts of replacement dairy heifer calves (n=42) with no prior exposure to F. hepatica, on three 32 
commercial dairy farms, were sampled over the course of a grazing season. Exposure was 33 
determined through F. hepatica-specific serum antibody ELISA and fluke egg counts. Concurrent 34 
changes in peripheral blood leukocyte sub-populations, lymphocyte proliferation and cytokine 35 
responses were measured. Relationships between fluke infection and immune responses were 36 
analysed using multivariable linear mixed effect models. 37 
All calves from one farm showed evidence of exposure, whilst cohorts from the remaining two farms 38 
remained negative over the grazing season.  A type-2 immune response was associated with 39 
exposure, with increased interleukin (IL)-4 production, IL-5 transcription and eosinophilia. 40 
Suppression of parasite-specific PBMC proliferation was evident; while decreased mitogen 41 
stimulated IFN-γ production suggested immunomodulation, which was not restricted to parasite-42 
specific responses. Our findings show that the global immune response is modulated towards a non-43 
proliferative type-2 state following natural challenge with F. hepatica. This has implications for 44 
vaccination programmes in terms of the timing of administration of vaccination programmes, and 45 
for host susceptibility to co-infecting pathogens. 46 
 47 
Introduction 48 
Liver fluke (Fasciola hepatica) is a parasitic trematode of global importance capable of infecting a 49 
wide range of vertebrate hosts, including humans. Fasciolosis is considered a major issue for global 50 
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food security, with over 600 million sheep and cattle thought to be infected worldwide (1). In cattle, 51 
clinical presentation ranges from severe, acute to chronic disease depending on intensity and stage 52 
of infection, although both result in significant morbidity and/or production losses.  Sub-clinical 53 
infections reduce weight gain, fertility and milk yield, which impacts on the economic viability of 54 
farm production systems (2, 3) and may last for months or years if untreated (4). 55 
Both incidence and prevalence of infection has increased across Europe over the last decade. This is 56 
largely attributed to climatic changes, namely increases in ambient temperatures and rainfall, 57 
favouring the development of both F. hepatica and its intermediate snail host, Galba truncatula.  As 58 
a result the range and prevalence of infection is increasing spatially and temporally, with changes in 59 
climate projected to further increase prevalence across Europe in the coming decades (5).  60 
Control of fasciolosis in livestock is currently based on a limited number of anthelmintics, of which 61 
triclabendazole (TCBZ) has been the most heavily used due to its efficacy against both adult and 62 
migratory juvenile stages of the parasite (6). TCBZ resistant F. hepatica infections in livestock are 63 
now  widely reported (7-12). There is therefore a need to develop novel approaches to control 64 
fasciolosis, with vaccination proposed as a potential adjunctive measure. 65 
Current vaccine trials are focussed on several immunodominant parasite antigens including 66 
cathepsin L proteases, glutathione S-transferase (GST), fatty acid binding proteins (FABP) and leucine 67 
aminopeptidase (LAP), which have been tried in a number of formulations and host species (cattle, 68 
sheep and goats) in both native and recombinant forms with levels of protection ranging from 0-72% 69 
protection (13, 14). In cattle, as with other ruminant species, protection is often only partial with 70 
reductions in fluke burden, egg output and viability observed in vaccinated animals compared to 71 
unvaccinated controls (15, 16). In these circumstances, mathematical modelling has shown that such 72 
partial protection must be induced in at least 90% of the herd to have a meaningful impact on 73 
disease control (17). 74 
Where vaccine-induced protection is demonstrated, it has been shown to correlate with parasite 75 
specific IgG2 isotype antibody titre and avidity and a reduction in arginase activity in CD14+ blood 76 
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monocyte derived macrophages, suggesting presence of a cell-mediated type-1 response is an 77 
important component of vaccine induced protection to F. hepatica (15, 18). Such responses, 78 
however, are not typically associated with infection in unvaccinated animals.  79 
Epidemiological evidence shows prevalence of F. hepatica infection increases with age (19) whilst 80 
chronically infected cattle remain susceptible to super-imposed experimental infections (20), 81 
suggesting an absence of any protective immunity.  Studies investigating the immune responses of 82 
cattle experimentally infected with F. hepatica initially show a pro-inflammatory response 83 
progressing over the course of infection towards a polarised, non-proliferative state. Parasite-84 
specific IL-2, IL-4 and IFN-γ production is described in hepatic lymph nodes at 10-14 days post 85 
infection (21), and parasite-specific IL-2 and IFN-γ production is also detected in peripheral blood 86 
mononuclear cells (PBMCs) from 1-3 weeks post infection (wpi), becoming absent by 5 wpi (22, 23). 87 
Similarly, mitogen and parasite-specific stimulated PBMC proliferation peaks around 2 wpi before 88 
returning to pre-infection levels (22-25).  Thereafter, responses progress towards a non-proliferative 89 
state associated with type-2 cytokines, an IgG1 isotype antibody response and an eosinophilia (20, 90 
24, 26).   By 10-12 wpi, when the parasite has reached the bile ducts and matured, there is a lack of 91 
mitogen or parasite-specific lymphocyte proliferation and an upregulation in IL-10 and TGF-β (27, 92 
28). It has been suggested that this fluke-induced modulation of the immune response facilitates its 93 
long term survival within the host (29), and may also impact on the host’s susceptibility to other, co-94 
infecting pathogens such as Salmonella Dublin (30) and Mycobacterium bovis, the causative agent of 95 
bovine tuberculosis (31, 32). 96 
Current vaccine development programmes are based on the assumption that immune responses 97 
observed in experimentally infected cattle are representative of those in naturally infected cattle. 98 
Little however is known about the immune responses associated with naturally acquired F. hepatica 99 
infections, specifically the early stages of infection, and the extent to which parasite-induced 100 
immunomodulation is induced. This may have implications for how vaccines are delivered in the 101 
field, and for understanding how the parasite may affect host susceptibility to co-infecting 102 
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pathogens. The aim of this study was therefore to define the immune responses in cohorts of dairy 103 
heifers on UK farms with typical management conditions and naturally exposed to challenge with F. 104 
hepatica. 105 
 106 
Materials and Methods 107 
Three commercial dairy farms were recruited into the study. They were identified as F. hepatica 108 
positive through bulk milk tank (BMT) antibody ELISA results (33) and positive composite faecal egg 109 
counts in adult cattle. On each farm, cohorts of replacement dairy heifer calves were recruited 110 
(n=42; 17, 17 and 8 animals from farms A, B and C, respectively) aged 90-377 days (mean=218.5, SD 111 
±62.0). These animals had been housed since birth so had not been exposed to F. hepatica. This was 112 
confirmed prior to turn out by faecal fluke egg counts and anti-F. hepatica IgG serum antibody ELISA 113 
(34). Negative ELISA results indicated no maternally derived antibodies were detectable at turnout. 114 
Animals were sampled monthly over the course of their first grazing season from turn-out in spring 115 
(April-May) through to housing in autumn (October-November) 2013. On each occasion blood was 116 
collected via jugular venepuncture into plain and EDTA coated vacutainers and faecal samples were 117 
collected rectally. BMT samples were also taken at each visit to assess changes in level of exposure 118 
within the milking herd. 119 
All the procedures used in this study were approved by the University of Liverpool's Veterinary 120 
Research ethics committee (VREC100) and adhered to the conditions of the project license granted 121 
by the UK Home Office (HOL PPL40/3621). All farm data was stored in accordance with the UK Data 122 
Protection Act (1998). 123 
 124 
F. hepatica serum and BMT IgG antibody ELISA 125 
Tubes containing clotted blood were centrifuged at 2,000g for 5 min, serum collected, stored at 4oC 126 
and tested for fluke specific antibody within 5 days.  A positive cut off of 20 Percent Positivity (PP) 127 
was used, giving a diagnostic sensitivity of 95% and specificity of 99% (34). BMT samples were 128 
6 
 
analysed using a positive cut-off value of ≥27PP, giving a diagnostic sensitivity of 96% and specificity 129 
of 80% as described previously (33). 130 
 131 
Fluke egg counts 132 
Faecal samples were stored at 4oC prior to analysis and examined for evidence of F. hepatica eggs 133 
following a standard sedimentation technique using 10g of faeces (35). This was performed on 134 
individual samples from the point of sero-conversion onwards, with counts done for every animal at 135 
the final time point irrespective of whether they had sero-converted. Nematode infections for all 136 
animals at each time point were assessed by faecal egg counts using the McMaster method with a 137 
sensitivity of 50 eggs per gram (epg) (36). 138 
 139 
Preparation of F. hepatica antigens 140 
Adult F. hepatica tegument and somatic antigen fractions for use in in vitro PBMC stimulation assays 141 
were prepared using previously described methods (23, 37); live adult fluke were collected from 142 
infected livers and incubated overnight to purge caecal contents, then washed three times in D-PBS 143 
(Sigma-Aldrich, St. Louis USA).  144 
Tegument antigen (TegAg) was prepared by placing fluke in D-PBS with 1% Nonidet P-40 (BDH 145 
Chemicals, Poole UK), 1ml per fluke, and agitating for 1 hour at 4oC. Pierce® Detergent Removal spin 146 
columns (Thermo Fisher Scientific, Waltham USA) were used to remove the Nonidet P-40 detergent.  147 
Somatic antigen (SomAg) was prepared from tegument-depleted fluke. These were washed in ice 148 
cold D-PBS and snap frozen overnight at -80oC. Fluke were then homogenised and diluted in D-PBS, 149 
0.5ml per fluke, and left to settle overnight at 4oC. The supernatant was collected, centrifuged at 150 
12,000g for 30 min at 4oC.  151 
Both antigens were filter sterilised and shown to contain negligible levels of endotoxin at tissue 152 
culture concentrations (Thermo-scientific) (38). Protein concentrations were estimated using a 153 




Haematology, PBMC purification and Flow cytometry 156 
Total and differential leukocyte counts were performed on EDTA-treated whole blood using a 157 
haemocytometer and thin blood smears, respectively, and used to calculate absolute counts for 158 
each leukocyte phenotype per ml of blood. 159 
PBMCs were isolated from whole blood in a lateral flow hood using OptiprepTM (Sigma-Aldrich, St. 160 
Louis USA) following manufacturer’s recommendations.  OptiprepTM was added to, and mixed with, 161 
EDTA treated whole blood, 1.3ml of optiprep per 10ml of blood, in a 50ml falcon tube onto which 162 
1ml 20mM tricine-buffered saline was layered. Samples were centrifuged at 1,000g for 35 min at 163 
20oC with the brake off following which the middle aqueous layer containing PBMCs was harvested 164 
and washed in PBS with 0.1% EDTA (Lonza, Bazel Switzerland) to a maximum volume of 20ml. 165 
Samples were centrifuged at 350g for 8 min at 20oC. Resulting supernatants were discarded and cell 166 
pellets re-suspended in 2ml of 0.9% NH4Cl haemolysis buffer and gently agitated for 1 min at room 167 
temperature. Samples were then washed in 20ml PBS EDTA and centrifuged at 150g for 8 min at 168 
20oC twice, with purified PBMCs then re-suspended and prepared for flow cytometry, proliferation 169 
and cytokine assays as described previously (67). 170 
One colour indirect immunofluorescence labelling was performed on PBMCs as previously described 171 
(39), with lineage specific monoclonal antibodies to identify bovine CD4+ and CD8+ (40), WC1+ (41) 172 
and CD14+ subsets (42). Sub-populations of leukocytes were analysed using a MACSQuant® analyser 173 
(Miltenyi Biotech Ltd.). PBMCs were isolated through gating of forward and side scatter channels, 174 
with adjustments made using a post-hoc analysis template (MACSQuantify v.2.4.1221.1, Miltenyi 175 
Biotech Ltd.) to ensure appropriate fit for all samples. Leukocyte sub-populations were identified 176 
and quantified through FITC-positive fluorescence emission and used to calculate absolute counts 177 
per ml of blood. 178 
 179 
Proliferation and cytokine measurements 180 
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PBMCs were adjusted to a concentration of 2 x 106 per ml in RPMI with 10% FCS and 100µg/ml 181 
penicillin and streptomycin and incubated in vitro with either ConA (5µg/ml), F. hepatica SomAg or 182 
TegAg (both 25µg/ml) or as unstimulated medium controls to assess proliferative and cytokine 183 
responses. For proliferation assays, 2 x 105 cells per well were cultured in triplicate in 96-well U-184 
bottomed plates (Corning Life Sciences, Corning USA) for 5 days at 37oC, 5% CO2.  On the 5
th day 185 
cultures were pulsed with 1µCi of [H3] tritiated thymidine (Perkin Elmer, Boston USA) for 5 hours 186 
then harvested onto glass filter mats and embedded in scintillation wax (Perkin Elmer, Boston USA). 187 
Beta-particle counts were measured with a MicroBeta2 plate counter (Perkin Elmer, Boston USA). 188 
The stimulation index (SI) of mitogen/antigen stimulated cultures was calculated as the fold increase 189 
in emission counts compared to medium controls. If SI for the ConA positive control was <2, 190 
proliferation values for both mitogen and antigen stimulated cultures were excluded from further 191 
analysis. 192 
For cytokine assays, PBMCs were incubated with ConA (5µg/ml), SomAg (25µg/ml) or as 193 
unstimulated medium controls for 48 hours at 37oC, 5% CO2 in flat bottomed 24 well cell culture 194 
plates (VWR, Radnor USA). Upon completion, culture supernatants were removed and stored at -195 
20oC with PBMCs stored separately at -20oC in RNAlater (Sigma-Aldrich, St. Louis USA). 196 
 197 
Cytokine production and transcription assays 198 
Cytokine production and transcription was measured in animals that sero-converted (farm A).  199 
Interferon (IFN)-γ and IL-4 concentrations were measured in supernatants using commercially 200 
available ELISAs following manufacturer’s protocols (MCA5638KZZ & MCA5892KZZ respectively, AbD 201 
Serotec, Raleigh USA). IL-10 production was measured in SomAg-stimulated and medium control 202 
cultures using a previously validated sandwich ELISA (43).  203 
Paired samples were used to investigate difference in TGF-β production in early versus chronic 204 
infection; samples for each individual animal were selected at the closest available time-point to 205 
sero-conversion to represent early infection, and from the last available time point to represent 206 
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chronic stages of infection.  Bio-active bovine TGF-β was measured in SomAg-stimulated and 207 
medium control cultures using a commercially available ELISA kit according to manufacturer’s 208 
recommendations (Promega, Madison USA) (44).  209 
Quantitative real-time (q)PCR was used to measure IL-2 and IL-5 mRNA against 28s housekeeper 210 
gene transcription in cultured PBMCs using previously published primers (NCBI accession No. 211 
AF154866, M12791 and EU915048.1, respectively). RNA extraction was performed using the RNeasy 212 
Mini kit (QIAGEN, Limburg Netherlands), and mRNA quantified with RiboGreen® (Invitrogen Life 213 
Technologies, Grand Island USA). Genomic DNA digestion and cDNA synthesis was then performed 214 
on 1μg of mRNA template for each sample using Quantitect Reverse transcriptase kit (QIAGEN, 215 
Limburg Netherlands). qPCR analysis was performed using a standard protocol with SYBR Green 216 
(Bioline reagents Ltd., London, UK) as described previously (45). 217 
Samples were assayed alongside known concentration standards diluted in a 10-fold series in 218 
100ng/μl yeast tRNA (Invitrogen Life Technologies, Grand Island USA) to prevent aggregation. 219 
Reactions were performed using a DNA Engine opticon 2 continuous Fluorescence detector.  220 
A final melting curve analysis was performed from 50-95°C to confirm the specificity of the 221 
amplification products. Sample copy numbers were determined using linear regression of standard 222 
concentrations following adjustment of Ct cut-off values to the log-linear phase of amplification. 223 
Results for IL-2 and IL-5 transcription are shown as relative expression against the 28s housekeeper 224 
gene (per million copies). 225 
 226 
Statistical Analysis 227 
Data analysis was performed using multivariable linear mixed effects models in the “nlme” package 228 
(46) in the R statistical software environment (47). Response variables (Y) chosen as indicators of 229 
exposure to F. hepatica were antibody PP value (Ab) to assess responses over the course of 230 
infection, and change in PP values (ΔAb) used to examine immunological parameters associated with 231 
the early stages of infection. This approach was taken as whilst PP values (Ab) increased over the 232 
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course of the study (Figure 1), the greatest changes in PP values (ΔAb) were seen at or soon after 233 
sero-conversion (Figure 2).  234 
Details of the structure of each statistical model are shown in (Table 1). For all models, leukocyte 235 
counts, PBMC proliferative responses, farm location, animal age, weight and days exposure (days at 236 
pasture) were modelled as fixed effects (Table 1), with individual animal identity modelled as a 237 
random effect to account for the increased relatedness of responses measured in the same animal. 238 
Models containing data from the fluke infected cohort (farm A) only (Table 1; lme_2 & 4) were 239 
analysed to allow the inclusion of the ex vivo PBMC cytokine responses measured as explanatory 240 
variables, thereby giving a more in-depth analysis of the immune responses present in these 241 
animals. Raw immunological data are summarized in supplemental material (Figures S1-6). 242 
Three models were produced using Ab as the response variable (Table 1; lme_1, 2 & 3). The first 243 
analysis (lme_1) included all data for all three farms over the 7 month sampling period. Model lme_2 244 
included data from the fluke infected cohort (farm A) only. Model lme_3 showed the analysis of data 245 
from fluke negative cohorts (farms B & C) only.  246 
When analysing immune responses associated with ΔAb, data collected pre- and post-247 
seroconversion was considered separately to allow the small changes in PP value associated with 248 
pre-seroconversion and late stage infection to be considered separately. Consequently, two models 249 
were produced using (ΔAb) as the response variable (Table 1; lme_4 & 5). The model lme_4 used 250 
post sero-conversion data from the fluke positive cohort (farm A) to measure changes in immune 251 
response associated with early exposure, whilst the model lme_5 used sero-negative data from 252 
farms A, B & C. 253 
Models containing only data from sero-negative measurements (lme_4 & 5) served to investigate 254 
potential physiological and/or age related changes, thus avoiding incorrectly attributing such 255 
observations to F. hepatica exposure. 256 
Prior to the linear mixed model analysis, the relationship between response and fixed effect 257 
explanatory variables was assessed, using a Box-Cox transformation (48) with power  determined 258 
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by maximum likelihood analysis used to transform the response variable to ensure an appropriate 259 
linear relationship (Table 1) (49).  260 
For models with Ab as the response variable (Y), an autoregressive correlation matrix of order 1 was 261 
also used to account for the relatedness of measurements resulting from repeated sampling, and in 262 
particular the fact that measurements taken close together in time are likely to be more similar than 263 
those taken further apart.  264 
Model refinement was then carried out using a stepwise Akaike information criterion (AIC) selection 265 
method (50) using complete case data for all models being compared with maximum likelihoods 266 
(ML) using the “MASS” package. The criterion of a reduction in AIC of 2 or greater was deemed 267 
indicative of model superiority (Table 1). The selected model was then fitted to all data for which 268 
complete observations were available using restricted maximum likelihoods (REML). This final model 269 
was checked for goodness of fit and normality using residual analysis and qq-plots, respectively 270 
(Figures S7-8). Missing (NA) values were considered to be “dropouts completely at random” (DCAR) 271 
since animals were moved between management groups throughout the grazing season for 272 
unrelated reasons (eg. stocking density, pasture management etc.) (51).  273 
Model outputs were interpreted by inspecting the coefficient (β) and associated standard error for 274 
each explanatory variable (x) included in the final model. The estimated coefficients indicated 275 
whether a positive or negative relationship was present between each explanatory variable (x) and 276 
the (transformed) response variable (Y), once all other explanatory variables present in the analysis 277 
had been taken into account. 278 
To assess TGF-β expression in early versus late stage infection, results were analysed using two-279 
tailed paired T-tests. Differences in measurement between medium control and SomAg stimulated 280 
PBMC cultures for each time point were analysed using unpaired two-tailed T-tests. 281 
 282 
Results 283 
1. Faecal egg counts and antibody responses 284 
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All calves remained healthy throughout the study, with no clinical signs observed as a result of F. 285 
hepatica infection, nematode burden or other disease. On each farm the adult milking herd was 286 
monitored monthly using a sample of milk from the bulk tank. All three herds tested positive on 287 
every occasion with BMT antibody values ranging from 33-50PP, 54-61PP and 79-114PP for farms A, 288 
B and C, respectively. 289 
Sero-conversion was observed in all 17 calves on farm A; PP values increased over the course of the 290 
study, reaching 37-98 PP at the final time point (Figure 1). Fluke eggs were detected in 10 of the 17 291 
animals from farm A by the final time point, with counts in all cases less than 1 egg per gram of 292 
faeces. Paramphistome eggs were also observed in low numbers in seven calves at the final time 293 
point. Six of these were positive for both F. hepatica and paramphistome eggs.  294 
PP values for the cohorts from farms B and C remained negative throughout the study except for 295 
two animals from farm B that had positive PP values at a single time point. These PP values were 296 
close to the cut off (20.3 & 24.7) and samples taken from these two calves on every other occasion 297 
were negative suggesting these results were false positives. All calves from farms B and C remained 298 
negative for fluke eggs for the duration of the study. 299 
Low numbers of nematode eggs were detected in calves on all three farms. Only two positive 300 
samples, with counts of 50 epg were detected on farm A at a single time point. Both trichostrongyle 301 
and Nematodirus spp. eggs were observed intermittently in 15/17 calves from farm B from August 302 
onwards, and trichostrongyle eggs were observed intermittently in 4/8 calves from farm C from July 303 
onwards. 304 
 305 
2. Immunological correlates of infection 306 
Twenty three immune and four signalment parameters were measured monthly for each calf, 307 
yielding over 1100 separate data points. To analyse these data we used multivariable linear mixed 308 
effect modelling. Two response variables were used: 1) antibody PP value (Ab) was used to indicate 309 
infection progression and 2) change in antibody (ΔAb) after sero-conversion was used to indicate the 310 
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point of first exposure and early stage of infection. ΔAb was used because the increase in PP values 311 
were greatest at the point of sero-conversion (Figure 2). 312 
 313 
i. Association between Ab and immune responses 314 
The output from the three models using Ab as the response variable (lme_1, 2 & 3) are shown in 315 
Table 2. Statistically significant positive associations were found in all three models between Ab 316 
(response variable) and days of exposure, showing that the longer the calves were grazing, the 317 
greater the likelihood of infection. A significant negative relationship between Ab and SomAg-318 
specific PBMC proliferation was also observed in all three models. 319 
When data from all three farms were used (lme_1), statistically significant negative associations 320 
were found for farms B and C relative to farm A. Statistically significant positive associations were 321 
detected for eosinophil and CD8+ PBMC counts and a negative coefficient was estimated for 322 
peripheral blood WC1+ counts. 323 
When the immune response data from farm A were used (lme_2), there was a negative association 324 
between Ab and ConA-induced IFN-γ production, and a positive association with ConA-induced IL-4 325 
and SomAg-induced IL-5 transcription. 326 
The model with data from fluke-negative cohorts on farms B & C (lme_3) showed a significant 327 
increase in peripheral CD8+ T-cell counts and corresponding decrease in CD4+ T-cell counts.  328 
 329 
ii. Association between ΔAb and immune responses 330 
When change in PP value (ΔAb) was used to indicate time of exposure (Table 3; lme_4), there was a 331 
significant negative association between ΔAb and days of exposure, suggesting infection occurred 332 
early after turnout and that ΔAb is a good measure of early infection. A negative association was also 333 
observed for SomAg-specific PBMC proliferation, whilst a positive associations were observed for 334 
TegAg-specific PBMC proliferation, ConA stimulated IL-4 production and SomAg stimulated IL-5 335 
transcription.  336 
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When using sero-negative data from all farms (Table 3; lme_5), there was a significant negative 337 
association with SomAg-specific PBMC proliferation, and a positive association with peripheral blood 338 
CD8+ counts. 339 
 340 
3. Cellular, proliferation and cytokine responses 341 
Eosinophil counts increased in all the animals on all three farms over the course of the study (Figure 342 
3). PBMC proliferation responses were variable both between animals and for individual animals at 343 
different time points.  The highest parasite-specific proliferation responses were observed in animals 344 
from farm A.  345 
Similar variation was observed in the cytokine responses of animals from farm A. An increase in 346 
ConA-stimulated IFN-γ production was observed following sero-conversion and there was evidence 347 
of ConA stimulated IL-4 production also. No IFN-γ production was detected in response to 348 
stimulation with SomAg, whilst only low levels of IL-4 production were observed. IL-2 and IL-5 349 
transcription was similarly variable between and within individuals over the course of the study in 350 
response to stimulation with both ConA and SomAg. 351 
No significant difference was found between levels of TGF-β expression in early versus late stage 352 
infection in either medium control or SomAg stimulated PBMC cultures (p=0.791 & 0.828, 353 
respectively), nor was any significant difference found between TGF-β levels in medium control or 354 
SomAg stimulated cultures at either time point (p=0.291 & 0.306, respectively). 355 
 356 
Discussion 357 
In this study, we have demonstrated that dairy calves develop a polarised, non-proliferative type-2 358 
response following primary natural challenge with F. hepatica. Studies using experimentally infected 359 
calves have described an initial inflammatory response comprised of mixed cytokine (IFN-γ and IL-4) 360 
production and antigen specific proliferation in PBMC cultures, which subside from 4-6 weeks post-361 
infection. Thereafter parasite-specific IgG1 and IL-4 responses are detected indicating a polarisation 362 
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towards a type-2 immune response as the infection progresses (20, 22, 23, 52). Our analysis of 363 
naturally infected calves show an association with increased eosinophil counts, IL-4 production, IL-5 364 
transcription and decreased IFN-γ production, indicating polarisation towards a type-2 response as 365 
infection progresses. Furthermore, the increased IL-4 and decreased IFN-γ production by ConA-366 
stimulated PBMCs suggests polarisation of the global T-cell response is present. This is consistent 367 
with findings in experimentally infected cattle (32, 53). The presence of a generalised type-2 immune 368 
environment may help explain why calves are less able to respond effectively to co-infecting 369 
pathogens. For example, cattle infected with F. hepatica are more susceptible to Salmonella Dublin 370 
infection (30, 32). 371 
Our findings differ from those obtained from experimentally infected calves however, in the rate and 372 
stage at which immune modulation is observed. Experimentally infected cattle have increased IL-2 373 
and IFN-γ production in the first 2-3 weeks post infection (22, 23), whilst our study suggests the early 374 
stages of natural infection are associated with increased IL-4 production and IL-5 transcription. 375 
Similarly, D. G. Clery and G. Mulcahy (22) showed parasite specific proliferation within 2 to 3 weeks 376 
post infection in experimentally infected calves, whilst our study detected a significant negative 377 
association between SomAg specific PBMC proliferation at all stages of infection. Early proliferative 378 
responses were observed in only 3/17 animals. For this study, samples were taken monthly, hence 379 
some transient early pro-inflammatory responses may have been missed. Nonetheless, our findings 380 
suggests that, unlike experimental infections, polarisation of the immune response in naturally-381 
acquired infection is present from very early in infection. 382 
These differences may relate to the infectious challenge administered in experimental infections 383 
compared to those encountered under field conditions. Most experimental infections have used 384 
either a single dose, or ‘trickle’ type infection, where boluses of several hundred, up to 1000 385 
metacercariae are administered per dose (26, 54). The epidemiology of F. hepatica in temperate 386 
regions typically results in small numbers of metacercariae present on pasture early in the spring 387 
followed by increasing numbers of metacercariae appearing on pasture towards the end of the 388 
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grazing season (55). Hence administering a large infectious challenge to immunologically naïve cattle 389 
may not be representative of normal field conditions and may result in a more profound innate 390 
cellular response during the early stages of experimental infection. 391 
Our results suggest that challenge at the start of the grazing season was not associated with 392 
detectable pro-inflammatory or proliferative responses. The immune-modulation induced during 393 
this primary challenge also may prevent any subsequent pro-inflammatory, proliferative responses 394 
developing later in the season when animals are exposed to a more substantial infectious challenge 395 
as pasture contamination increases. These findings have implications for vaccine programmes, since 396 
current efforts are focussed on enhancing cell-mediated type-1 responses (15, 18). Our results 397 
suggest the efficacy of such vaccines would be negatively impacted if administered following natural 398 
exposure to F. hepatica under field conditions. These vaccines would therefore need to be 399 
administered and be fully effective prior to any exposure to infection. 400 
In experimentally infected calves, a systemic regulatory response develops during the chronic stages 401 
of infection characterised by increased parasite specific IL-10 and TGF-β production by PBMC (27). In 402 
this study, we found no significant association between infection status and parasite-specific IL-10 or 403 
TGF-β production by PBMCs. Again, this may relate to differences in the way in which the calves 404 
were exposed to infection, although it is possible that such regulatory responses were present in 405 
local and regional lymph nodes, as this has been observed previously in cattle and sheep harbouring 406 
naturally acquired, chronic F. hepatica infections (28, 56). 407 
Eosinophilia is a feature of many helminth infections. Calves on farm A were treated with three 408 
doses of ivermectin over the course of the grazing season, and nematode egg counts remained at or 409 
close to zero throughout the study period. The eosinophilia observed in this cohort was most likely 410 
to be in response to F. hepatica rather than nematode infection, particularly since there was a 411 
significant positive relationship between fluke Ab PP value and both peripheral eosinophil counts 412 
and SomAg-stimulated IL-5 transcription. This is consistent with previous findings of eosinophilia in 413 
F. hepatica infected cattle (26, 57). 414 
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Both fluke infection and specific fluke antigens are known to have immuno-suppressive and/or 415 
modulatory effects on both the innate and adaptive immune responses (20, 27, 52, 58). Differences 416 
between the relationships of SomAg and TegAg PBMC proliferation and the early stages F. hepatica 417 
exposure (ΔAb) may be the result of differences in composition of these two antigen fractions and 418 
their functions in vivo. Overall, however, our results show that in naturally infected calves, there is 419 
an absence and/or suppression of parasite-specific T cell proliferation.  420 
The negative relationship between Ab and WC1+ PBMC counts is most likely to be due to age and 421 
maturation of the immune system. WC1+ γδT-cells are known to decrease in number in the 422 
peripheral blood as cattle mature. WC1+ cell populations constitute approximately 15% of PBMCs in 423 
calves aged 3-12 months in age, decreasing to around 5% by 3 years of age (59). In our study, 424 
animals ranged in age from 90-377 days at the beginning and were 310-587 days of age by the end. 425 
The respective mean WC1+ PBMC counts were 20% (6-32%) and 6% (0.5-24%). Similarly, the positive 426 
relationship between Ab and CD8+ PBMC counts may also signify the normal maturation of the 427 
immune system rather than a direct impact of infection since this was also observed in uninfected 428 
animals. 429 
In spite of evidence from the adult milking herd that F. hepatica infection was present on all three 430 
farms, the calves on farms B and C showed no evidence of infection. In both cases these calves were 431 
kept in different parts of the farm and did not share pastures with the adult cows. In contrast the 432 
cohort on farm A was managed in a rotational grazing system that included pastures grazed by adult 433 
cattle. This suggests the fields used for calves on farms B and C had no habitat suitable for the 434 
intermediate host, Galba truncatula and were not contaminated with metacercariae. 435 
In this study, multivariable linear mixed-effect regression models were used to analyse a longitudinal 436 
set of data from cattle naturally exposed to F. hepatica. This analysis was useful since it allowed the 437 
simultaneous assessment of multiple immunological variables to identify the key parameters 438 
associated with infection. To the best of our knowledge this is the first time such techniques have 439 
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been used to analyse complex immunological responses to natural infection in livestock and may 440 
represent a potentially useful template for future studies. 441 
In conclusion, through analysis of a longitudinal dataset using multivariable linear mixed-effect 442 
regression analysis we have demonstrated that natural exposure to F. hepatica, dairy heifers results 443 
in a generalised type-2 immune state with concomittent suppression of proliferation responses. This 444 
has significance for both vaccine administration programmes and susceptibility to other common co-445 
infecting pathogens of livestock. 446 
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Table 1: Linear mixed effects model structures. Response variable (Y) indicates the subject of each respective model. Box-Cox value (λ) is the optimal 614 
transformation factor for the response variable to ensure linear fit to the proposed fixed-effect variables. Where nil is quoted, transformation was not 615 
required. For initial fixed-effect explanatory variables “Leuk. counts” refers collectively to leukocyte count data (eosinophils (Eo), neutrophils (No) and CD4+, 616 
CD8+, WC1+ & CD14+ PBMCs) per ml of peripheral blood, “PBMC prolifn.” to PBMC proliferation data (ConA, SomAg and TegAg stimulated cultures), whilst 617 
“PBMC cytokines” refers to all available PBMC cytokine production and transcription data (IFN-γ, IL-4 and IL-10 production, IL-2 & IL-5 relative gene 618 
transcription). For cytokine data present as final explanatory variables square parentheses [] indicate the culture conditions present; medium control (Med), 619 







value (λ) Data analysed 
Initial fixed-effect explanatory variables (x); 
[AIC value] 
Final explanatory variables (x) following stepwise AIC 
selection; [AIC value] 
lme_1 Ab -0.2 All data 
Farm + Days exposure + Age + Weight + 
Leuk. counts + CD4:CD8 ratio + PBMC 
prolifn.; [AIC = 44.98] 
Farm + Days exposure + Eo + CD4 + CD8 + WC1 + SomAg  
prolifn. + TegAg  prolifn.; [AIC = 37.99] 
lme_2 Ab 0.2 Farm A 
Days Exposure + Age + Weight + Leuk. counts 
+ CD4:CD8 ratio + PBMC prolifn. + PBMC 
cytokines; [AIC = 166.04] 
Days Exposure + Eo + SomAg prolifn. + IFNγ [ConA] +  
IFNγ [SomAg] + IL-4 [ConA] + IL-10 [Med] + IL-10 [SomAg] 
+ IL-2 [ConA] + IL-5 [SomAg]; [AIC = 145.57] 
lme_3 ΔAb nil 
Sero-positive 
values; Farm A 
(see lme_2); [AIC = 354.80] 
Days exposure + CD4 + WC1 + SomAg  prolifn. + TegAg  
prolifn. +IL-4 [ConA] + IL-5 [SomAg]; [AIC = 329.74] 
lme_4 Ab -0.2 Farms B & C (see lme_1); [AIC = 38.29] 
Farm + Days exposure + SomAg prolifn + Eo + CD4 + CD8 
+ WC1; [AIC = 26.06] 
lme_5 ΔAb nil 
Sero-negative 
values;  
Farms A, B & C 
(see lme_1); [AIC = 653.12] 
Farm + CD4 + CD8 + CD4:CD8 ratio + SomAg  prolifn. + 
TegAg  prolifn.; [AIC = 640.33] 
lme_6 ΔAb nil Farms B & C (see lme_1); [AIC = 580.03] Eo + CD8; [AIC = 561.09] 
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Table 2: Multivariable linear mixed effect model outputs for anti-F. hepatica antibody PP value 623 
(Ab) as response variable (Y). Statistically significant (p<0.05) explanatory variables (x) are shown 624 
with corresponding coefficient (β) and standard error (SE) values to describe their respective 625 
relationships with Ab. Values rounded to 3 decimal places, or 1 significant figure. 626 







error (SE) P-value 
lme_1 
All data 
Farm B -0.687 0.077 <0.001 
Farm C -0.874 0.087 <0.001 
Days exposure -0.005 <0.001 <0.001 
Eφ/ml -0.0001 0.00004 0.024 
CD8 /ml -0.0002 <0.0001 0.016 
WC1/ml -0.0001 0.00004 0.028 




Days exposure -0.027 0.003 <0.001 
SomAg -0.012 0.005 0.039 
[ConA] IFNγ -0.0001 <0.00006 0.026 
[ConA] IL-4 -0.0005 0.0002 0.039 
[SomAg] IL-5 -0.003 0.001 0.012 
lme_3 
Farms B & C 
(negative cohorts) 
Farm C -0.201 0.086 0.029 
Days exposure -0.004 <0.001 <0.001 
CD4/ml -0.0001 0.00004 0.010 
CD8/ml -0.0004 0.0001 <0.001 
SomAg -0.007 0.003 0.042 
 627 
  628 
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Table 3: Multivariable linear mixed effect model outputs for change in antibody PP value (ΔAb) as 629 
response variable (Y). Statistically significant (p<0.05) explanatory variables (x) are shown with the 630 
coefficient (β) and standard error (SE) values to describe their respective relationships with ΔAb. 631 








error (SE) P-value 
lme_4 
Farm A  
(post sero-conversion) 
 
Days exposure -0.354 0.107 0.004 
SomAg -2.794 1.211 0.034 
TegAg 2.254 1.064 0.049 
[ConA] IL-4 0.012 0.050 0.033 
[SomAg] IL-5 0.071 0.029 0.026 
lme_5 
Farms A, B & C 
(Sero-negative values) 
 
Farm B -12.009 4.675 0.015 
Farm C -14.760 5.096 0.006 
CD8/ml 0.027 0.009 0.008 
SomAg -0.621 0.276 0.027 
TegAg 0.712 0.248 0.005 
  633 
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Figure 1: Antibody PP values of individual animals over the study period for the three dairy farms 634 
(A, B & C). Diagnostic positive cut-off value (PP=20) is denoted by horizontal line. Month of sampling 635 
denotes the time point for each sequential  visit to each farm. 636 
 637 
Figure 2: Change in antibody PP value (ΔAb) over the course of infection for farm A. Positive values 638 
indicate an increase in Ab PP value from one time point to the next, and negative values denote a 639 
decrease in Ab PP value compared to the previous month. Values from 1 month prior to sero-640 
conversion (-1) are considered separately from other sero-negative values (-ve) as infection may 641 
have been present at this time point but the animals had not seroconverted.  In experimentally 642 
infected animals, seroconversion occurs 2-4 weeks post-infection (34). 643 
 644 
Figure 3: Peripheral blood eosinophil counts for individual animals over the study period for the 645 
three dairy farms (A, B & C). Month of sampling denotes the time point for each sequential sampling 646 
visit. 647 



